Progressive Strength Training in Spinal Muscular Atrophy

Status Active, not recruiting

Clinical Trial Summary

The proposed feasibility study is necessary to test if children and young adults will participate in and adhere to a 12-week, home-based, supervised progressive strength training exercise program and to obtain preliminary data that will subsequently allow us to determine the safety and impact of strength training in spinal muscular atrophy. Our pilot study will address 3 aims: (1) Ascertain the feasibility of, and potential barriers to, participation in and adherence to a 12-week home-based, supervised, progressive strength training exercise program in children and young adults aged 5-21 years with SMA types II and III; (2) Determine the safety and tolerability of progressive strength training in a pilot study sample of children and young adults with SMA types II and III; and (3) Determine candidate outcome measures.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01233817
Study type	Interventional
Source	University of Utah
Contact
Status	Active, not recruiting
Phase	N/A
Start date	June 2010

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00533221` - Pilot Study of Growth Hormon to Treat SMA Typ II and III	Phase 2
Completed	`NCT02908685` - A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants	Phase 2
Recruiting	`NCT05575011` - A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB115	Phase 1
Completed	`NCT05073133` - Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (OFELIA)	Phase 4
Terminated	`NCT02240355` - A Study of RO6885247 in Adult and Pediatric Patients With Spinal Muscular Atrophy (MOONFISH)	Phase 1
Recruiting	`NCT05042921` - Pediatric Spinal Muscular Atrophy (SMA) China Registry
Completed	`NCT04419233` - Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection
Recruiting	`NCT05861986` - A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy	Phase 4
Completed	`NCT00466349` - International SMA Patient Registry
Completed	`NCT03920865` - A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function	Phase 1
Recruiting	`NCT05481164` - Newborn Screening for Spinal Muscular Atrophy
Completed	`NCT04089566` - Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy	Phase 3
Recruiting	`NCT05861999` - A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy	Phase 4
Recruiting	`NCT05755451` - Natural History of SMA
Recruiting	`NCT04317794` - Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium)
Active, not recruiting	`NCT05618379` - Adult Spinal Muscular Atrophy (SMA) China Registry
Active, not recruiting	`NCT04488133` - A Study of Nusinersen Among Participants With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec	Phase 4
Completed	`NCT03781479` - Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients	Phase 2
Completed	`NCT00568802` - A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients	Phase 1/Phase 2
Completed	`NCT00568698` - A Pilot Therapeutic Trial Using Hydroxyurea in Type I Spinal Muscular Atrophy Patients	Phase 1/Phase 2